ASH 2019

61st Annual Meeting & Exposition of the American Society of Hematology

Oral selinexor+pomalidomide+dexamethasone offers hope for heavily pre-treated multiple myeloma

Rivaroxaban is safe and effective for paediatric venous thromboembolism

CAR T-cell therapy successful in older non-Hodgkin’s lymphoma patients

Mild renal impairment in African Americans does not affect OS in AML

20-year follow-up of imatinib in chronic myeloid leukaemia

Oral Azacitidine Improves Overall Survival in Patients with AML in Remission: a Promise for Maintenance Therapy?

Likely New Standard of Care: Blinatumomab for Children with Relapsed B-ALL

Pivotal Phase 3 Trial in Cold Agglutinin Disease

Dual-target CAR T therapy Yields 100% Response in R/R MM

BCL11A as Novel Target in Gene Therapy for Sickle Cell Disease

Top image: @ iStockPhoto: ustas7777777

The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.